Shares in Futura Medical PLC jumped as much as 10% after the company upgraded its 2025 revenue forecast to £1.7 million and reported a robust year-end cash balance, extending its financial runway into late 2026.
The launch of Anthropic's new multi-functional AI platform, Claude Cowork, has triggered a sharp sell-off in software stocks as investors fear widespread disruption to the SaaS business model.
Boston Scientific shares tumbled nearly 14% Thursday after the medical device giant's first-quarter guidance fell short of expectations, sparking a sell-off despite the company posting better-than-expected fourth-quarter earnings.
Novo Nordisk announced Wednesday the upcoming U.S. launch of its oral semaglutide tablets under the Ozempic brand, with FDA approval secured for multiple doses. The move marks a significant shift for the popular diabetes treatment from injection to pill form.
Newly released DOJ files detail communications showing Brock Pierce facilitated Epstein's entry into Coinbase's Series C round, while later emails reveal Blockchain Capital's attempts to buy his stake years later.
A poignant national touring exhibition, born from a mother's grief for her son Oscar Grant, uses birthday remembrances to humanize victims of police brutality and examine the enduring impact on communities.
A major human rights review accuses the Labour government of eroding civil liberties through expansive surveillance, restrictive protest laws, and the controversial banning of activist groups, raising alarms about the state of democracy in Britain.
The U.S. Supreme Court has declined to block California's newly adopted congressional district map, a move seen as countering Republican redistricting efforts in Texas. The decision is expected to bolster Democratic prospects in the battle for control of the House of Representatives in the upcoming midterm elections.
The UN children's agency is urging nations worldwide to outlaw the creation of AI-generated child sexual abuse material, citing alarming reports of a surge in such fabricated content. The call comes as Britain moves to become the first country to explicitly criminalize the practice.
The Minneapolis City Council has advanced a $500,000 funding increase for immigrant legal services, doubling the city's annual commitment as local leaders respond to heightened federal immigration operations and growing community demand.
Enphase Energy's latest quarterly results and bullish 2026 outlook have reignited investor interest, sparking a sharp rally. However, the microinverter leader's path forward is clouded by sector headwinds and a stark contrast between recent gains and steep annual losses.
The parent company of Titleist and FootJoy has seen its fair value estimate rise modestly to around $87, reflecting a cautious but growing confidence in its ability to meet expectations, even as some analysts warn the stock may be nearing fair price.
Super Micro Computer's stellar Q2 earnings, fueled by AI server demand, have prompted a raised annual outlook to over $40 billion. Yet, the celebration is tempered by stark realities: margins are razor-thin, and the company's fortunes are increasingly tied to one massive data center customer, reshaping its risk profile for investors.
As AutoZone's fair value estimate adjusts to around $4,210, a nuanced tug-of-war emerges on Wall Street. Analysts are fine-tuning models, balancing long-term operational confidence against near-term consumer spending concerns, reshaping the investment narrative for the auto parts retailer.
Merck & Co. posted strong 2025 sales but offered a 2026 revenue forecast below Wall Street's expectations. Despite this, its shares have rallied sharply over the past year, leading analysts to question whether the market is pricing in future pipeline success or overlooking near-term headwinds.
Volkswagen Group is reportedly reconsidering the future of the all-electric Porsche 718 Boxster and Cayman, citing development hurdles and rising costs. The potential move signals a strategic pivot towards core, high-volume electric vehicles and stricter financial discipline across the auto giant's portfolio.
French biotech ABIVAX reports positive Phase 3 results for its lead drug obefazimod in ulcerative colitis, meeting key secondary endpoints with a clean safety profile. With funding secured through late 2027, the company plans to advance pivotal maintenance and Crohn's disease trials, reshaping its investment narrative.
Elon Musk's SpaceX is broadening its IPO syndicate, holding pitches with non-U.S. banks in January. The move comes as the company, now set to include xAI, prepares for a record-breaking public offering later this year that could value the combined entity at $1.25 trillion.
Elon Musk's social media platform X is under unprecedented global scrutiny, with recent controversies over its AI chatbot Grok and content moderation policies prompting regulatory actions and penalties that threaten its core business model and future ambitions.
As U.S. and Iranian officials prepare for high-stakes talks, a series of dangerous aerial and naval incidents in the Gulf underscores the fragile line between diplomacy and escalation. Analysts warn President Trump's threats face a critical credibility test, drawing inevitable parallels to a previous administration's pivotal moment.
